Zaloguj się

Gotowe bibliografie tematyczne / Neurodegenerative disease / Książki

Książki na temat „Neurodegenerative disease”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Neurodegenerative disease.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 24 sierpnia 2024

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „Neurodegenerative disease”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

W, Langston J., i Young Anne B. 1947-, red. Neurotoxins and neurodegenerative disease. New York, N.Y: New York Academy of Sciences, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Avila, Jesus, Jose J. Lucas i Felix Hernandez, red. Animal Models for Neurodegenerative Disease. Cambridge: Royal Society of Chemistry, 2011. http://dx.doi.org/10.1039/9781849732758.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Saghir, Atif N. Free radicals in neurodegenerative disease. Birmingham: University of Birmingham, 1996.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

1952-, Marwah J., i Teitelbaum Herman, red. Advances in neurodegenerative disorders. Scottsdale, Ariz: Prominent Press, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Board, National Radiological Protection, red. ELF electromagnetic fields and neurodegenerative disease. Didcot: NRPB, 2001.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Singh, Sarika, i Neeraj Joshi, red. Pathology, Prevention and Therapeutics of Neurodegenerative Disease. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-0944-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Mauro, Fasano, red. The proteomic approach in neurodegenerative disease research. Trivandrum, Kerala, India: Research Signpost, 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Mauro, Fasano, red. The proteomic approach in neurodegenerative disease research. Trivandrum, Kerala, India: Research Signpost, 2007.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Selkoe, Dennis J., i Yves Christen, red. Immunization Against Alzheimer’s Disease and Other Neurodegenerative Disorders. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-59332-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

von, Bernhardi Rommy, i Inestrosa Nibaldo C, red. Neurodegenerative diseases: From molecular concepts to therapeutic targets. New York: Nova Biomedical Books, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

Amritpal, Mudher, i Newman Tracey, red. Drosophila: A toolbox for the study of neurodegenerative disease. New York: Taylor & Francis Group, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Amritpal, Mudher, i Newman Tracey, red. Drosophila: A toolbox for the study of neurodegenerative disease. New York: Taylor & Francis Group, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Amritpal, Mudher, i Newman Tracey, red. Drosophila: A toolbox for the study of neurodegenerative disease. New York: Taylor & Francis Group, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

I, Tröster Alexander, red. Memory in neurodegenerative disease: Biological, cognitive, and clinical perspectives. Cambridge, UK: Cambridge University Press, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Chadwick, Derek J., i Jamie A. Goode, red. Neural Transplantation in Neurodegenerative Disease: Current Status and New Directions. Chichester, UK: John Wiley & Sons, Ltd, 2000. http://dx.doi.org/10.1002/0470870834.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Möller, Thomas. Huntington Disease, Parkinson Disease, and Other Neurodegenerative Diseases. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199794591.003.0065.

Pełny tekst źródła

Streszczenie:

This is a digitally enhanced text. Readers can also see the coverage of this topic area in the second edition of Neuroglia. The second edition of Neuroglia was first published digitally in Oxford Scholarship Online and the bibliographic details provided, if cited, will direct people to that version of the text. Readers can also see the coverage of this topic area in the ...

Style APA, Harvard, Vancouver, ISO itp.

17

Prasad, Kedar N. Neurodegenerative Disease and Micronutrients. CRC Press, 2014. http://dx.doi.org/10.1201/b17497.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Metal Related Neurodegenerative Disease. Elsevier, 2013. http://dx.doi.org/10.1016/c2012-0-03090-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Tröster, Alexander I., red. Memory in Neurodegenerative Disease. Cambridge University Press, 1998. http://dx.doi.org/10.1017/cbo9780511544378.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Metabolomics in Neurodegenerative Disease. MDPI, 2020. http://dx.doi.org/10.3390/books978-3-03928-041-4.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Crish, Samuel D., Robert W. Burgess, Denise M. Inman, Christine M. Dengler-Crish, Jason R. Richardson i Brett Schofield, red. Axonopathy in Neurodegenerative Disease. Frontiers Media SA, 2019. http://dx.doi.org/10.3389/978-2-88945-680-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Trojanowski, J. O. PENN Neurodegenerative Disease Research. S Karger Pub, 2008.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Bhatia, Kailash P., i Susanne Schneider. Metal Related Neurodegenerative Disease. Elsevier Science & Technology Books, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Books, Gregg. Prions and Neurodegenerative Disease. Independently Published, 2020.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Metal Related Neurodegenerative Disease. Elsevier Science & Technology Books, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Neurodegenerative Disease Research and Commonalities with Metabolic Diseases. Elsevier, 2020. http://dx.doi.org/10.1016/s0074-7742(20)x0006-7.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Mattson, Mark P., Jan Oscarsson, Grazyna Soderbom i Russell Esterline. Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Neurodegenerative Disease Research and Commonalities with Metabolic Diseases. Elsevier Science & Technology Books, 2020.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Metabolic and Bioenergetic Drivers of Neurodegenerative Disease: Treating neurodegenerative diseases as metabolic diseases. Elsevier, 2020. http://dx.doi.org/10.1016/s0074-7742(20)x0007-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Animal Models for Neurodegenerative Disease. Royal Society of Chemistry, The, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

30

Animal Models for Neurodegenerative Disease. Royal Society of Chemistry, The, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Novartis, Foundation. Neural Transplantation in Neurodegenerative Disease. Wiley & Sons, Incorporated, John, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Zhou, Yongxia. Multiparametric Imaging in Neurodegenerative Disease. Nova Science Publishers, Incorporated, 2020.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Zhou, Yongxia. Multiparametric Imaging in Neurodegenerative Disease. Nova Science Publishers, Incorporated, 2020.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Lewis, Patrick A., i Jennifer E. Spillane. Molecular Pathology of Neurodegenerative Disease. Elsevier Science & Technology Books, 2018.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

Omic Studies of Neurodegenerative Disease. Elsevier Science & Technology Books, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Animal Models of Neurological Disease, I: Neurodegenerative Diseases. Humana Press, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

37

(Editor), C. Haass, i G. Multhaup (Editor), red. Cellular Mechanisms of Alzheimer's Disease: Neurodegenerative Diseases 2006. S Karger Pub, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Boulton, Alan A., Glen B. Baker i Roger F. Butterworth. Animal Models of Neurological Disease, I: Neurodegenerative Diseases. Humana Press, 2013.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Cummings, Jeffrey L., i Jagan A. Pillai, red. Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.001.0001.

Pełny tekst źródła

Streszczenie:

With an increasingly aging population, neurodegenerative diseases-such as Alzheimer’s disease, Lewy body dementia, frontotemporal dementia, and Parkinson’s disease-are becoming more prevalent in the world. This is an area of rapidly growing high-impact research as these neurodegenerative diseases are a huge burden for individuals, families, and societies both in quality of life and in healthcare costs. Finding novel therapeutic targets for neurodegenerative diseases is the premier medical challenge for this century. Classically each of these diseases has been viewed as a distinct entity with well-delineated clinical and pathological features. Recent research findings have revealed multiple commonalities across them; proteomic, genetic, cellular, and network mechanisms across neurodegenerative diseases. This conceptual revolution in our understanding of these neurodegenerative diseases as sharing unifying features is underpinned by underlying protein misfolding dysfunction and its consequences over time. As we search for new therapies and management of these neurodegenerative diseases, this book provides an effective source book of insights from experts that have played key roles in this conceptual revolution. Our goal is to enable better care of patients and to help build collaboration across research in multiple specializations that could help advance future insights and facilitate novel therapeutics.

Style APA, Harvard, Vancouver, ISO itp.

40

Cummings, Jeffrey L., i Jagan A. Pillai. Neurodegenerative Diseases. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0001.

Pełny tekst źródła

Streszczenie:

Neurodegenerative diseases (NDDs) are growing in frequency and represent a major threat to public health. Advances in scientific progress have made it clear that NDDs share many underlying processes, including shared intracellular mechanisms such as protein misfolding and aggregation, cell-to-cell prion-like spread, growth factor signaling abnormalities, RNA and DNA disturbances, glial cell changes, and neuronal loss. Transmitter deficits are shared across many types of disorders. Means of studying NDDs with human iPS cells and transgenic models are similar. The progression of NDDs through asymptomatic, prodromal, and manifest stages is shared across disorders. Clinical features of NDDs, including cognitive impairment, disease progression, age-related effects, terminal stages, neuropsychiatric manifestations, and functional disorders and disability, have many common elements. Clinical trials, biomarkers, brain imaging, and regulatory aspects of NDD can share information across NDDs. Disease-modifying and transmitter-based therapeutic interventions, clinical trials, and regulatory approaches to treatments for NDDs are also similar.

Style APA, Harvard, Vancouver, ISO itp.

41

(Editor), Alan A. Boulton, Glen B. Baker (Editor) i Roger F. Butterworth (Editor), red. Animal Models of Neurological Disease, I: Neurodegenerative Diseases (Neuromethods). Humana Press, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

Schiesser, William E. Computational Chemotaxis Models for Neurodegenerative Disease. WORLD SCIENTIFIC, 2017. http://dx.doi.org/10.1142/10377.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Zhang, Ke, Chao Wang, Junliang Yuan i Yu Deng, red. Peripheral Immune System and Neurodegenerative Disease. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-975-9.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Drouin-Ouellet, Janelle, i Roger A. Barker. Disease-Modifying Therapies in Neurodegenerative Disorders. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780190233563.003.0016.

Pełny tekst źródła

Streszczenie:

The recent identification of the genetic basis of many neurodegenerative disorders (NDDs), coupled with a greater understanding of their pathophysiology, has enabled better therapeutic strategies to be identified and tried. This includes approaches that target critical specific nodes in the disease pathways, for example, agents that modulate levels of mutant huntingtin in Huntington’s disease. In addition to these highly specific targeted therapies, there is also a growing realization that more generic lifestyle therapies influencing whole brain health may also have merit in treating these conditions-such as diet and exercise. This chapter explores the different approaches and agents used to try to modify the course of a range of NDDs, and highlights their progress relative to the clinic and the patients suffering with these currently incurable conditions.

Style APA, Harvard, Vancouver, ISO itp.

45

(Editor), M. A. Yenari, i Rona Greenberg Giffard (Editor), red. Glia And Inflammation in Neurodegenerative Disease. Nova Science Publishers, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

Prasad, Kedar N. Neurodegenerative Disease and Micronutrients: Prevention and Treatment. Taylor & Francis Group, 2014.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Omic Studies of Neurodegenerative Disease: Part A. Elsevier, 2015. http://dx.doi.org/10.1016/s0074-7742(15)x0003-1.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Omic Studies of Neurodegenerative Disease: Part B. Elsevier, 2015. http://dx.doi.org/10.1016/s0074-7742(15)x0004-3.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Hurley, Michael J. Omic Studies of Neurodegenerative Disease - Part A. Elsevier Science & Technology Books, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Hurley, Michael J. Omic Studies of Neurodegenerative Disease - Part B. Elsevier Science & Technology Books, 2015.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!